Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) ROE %: 23.86% (As of Mar. 2026) — 60% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605016 Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
96 GF Score
Price ¥21.50
GF Value ¥22.57
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Shandong Bailong Chuangyuan Bio-Tech Co ROE %?

Shandong Bailong Chuangyuan Bio-Tech Co SHSE:605016 -9.24% 96 ROE % is 23.86% as of Mar. 2026, which is 60% above its 10-year median of 14.88. GuruFocus rates SHSE:605016 with a GF Score™ of 96/100 and a GF Value™ of ¥22.57 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,925 Consumer Packaged Goods companies, Shandong Bailong Chuangyuan Bio-Tech Co ranks better than 87.58% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shandong Bailong Chuangyuan Bio-Tech Co's annualized net income for the quarter that ended in Mar. 2026 was ¥482 Mil. Shandong Bailong Chuangyuan Bio-Tech Co's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ¥2,022 Mil. Therefore, Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROE % for the quarter that ended in Mar. 2026 was 23.86%.

The historical rank and industry rank for Shandong Bailong Chuangyuan Bio-Tech Co's ROE % or its related term are showing as below:

SHSE:605016' s ROE % Range Over the Past 10 Years
Min: 11.03   Med: 14.88   Max: 21.49
Current: 21.49

During the past 10 years, Shandong Bailong Chuangyuan Bio-Tech Co's highest ROE % was 21.49%. The lowest was 11.03%. And the median was 14.88%.

SHSE:605016's ROE % is ranked better than
87.58% of 1925 companies
in the Consumer Packaged Goods industry
Industry Median: 6.78 vs SHSE:605016: 21.49

Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=482.344/2021.759
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(482.344 / 1570.44)*(1570.44 / 2618.132)*(2618.132 / 2021.759)
=Net Margin %*Asset Turnover*Equity Multiplier
=30.71 %*0.5998*1.295
=ROA %*Equity Multiplier
=18.42 %*1.295
=23.86 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=482.344/2021.759
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (482.344 / 568.84) * (568.84 / 571.308) * (571.308 / 1570.44) * (1570.44 / 2618.132) * (2618.132 / 2021.759)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8479 * 0.9957 * 36.38 % * 0.5998 * 1.295
=23.86 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shandong Bailong Chuangyuan Bio-Tech Co ROE % Related Terms


Shandong Bailong Chuangyuan Bio-Tech Co ROE % Historical Data

* Premium members only.

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Bailong Chuangyuan Bio-Tech Co ROE % Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.03 11.83 13.53 15.41 20.25

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.94 19.83 20.61 21.66 23.86

SHSE:605016 vs KHC, GIS: ROE % Comparison

For the Packaged Foods subindustry, Shandong Bailong Chuangyuan Bio-Tech Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Bailong Chuangyuan Bio-Tech Co ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Bailong Chuangyuan Bio-Tech Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shandong Bailong Chuangyuan Bio-Tech Co's ROE % falls into.


SHSE:605016
96GF Score
Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Bailong Chuangyuan Bio-Tech Co ROE % Calculation

Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=368.55/( (1679.237+1961.466)/ 2 )
=368.55/1820.3515
=20.25 %

Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=482.344/( (1961.466+2082.052)/ 2 )
=482.344/2021.759
=23.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 23.86% mean?
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a ROE % of 23.86% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. This is 60% above median its historical median of 14.88. Over the past decade, Shandong Bailong Chuangyuan Bio-Tech Co's ROE % has ranged from 11.03 to 21.49. According to the industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #239 out of 1925 companies in the Consumer Packaged Goods industry, placing it in the top 12.4%.
Is Shandong Bailong Chuangyuan Bio-Tech Co's ROE % too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current ROE % of 23.86% is 60% above median its 10-year median of 14.88. Over the past 10 years, this metric has ranged from a low of 11.03 to a high of 21.49. The Consumer Packaged Goods industry median ROE % is 6.78. Shandong Bailong Chuangyuan Bio-Tech Co's value of 23.86% is 251.9% above this industry median. Based on the distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #239 out of 1925 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's ROE % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #239 out of 1925 companies for ROE %. This places Shandong Bailong Chuangyuan Bio-Tech Co in the top 12% of its industry — outperforming the majority of peers. The industry median ROE % is 6.78. Shandong Bailong Chuangyuan Bio-Tech Co's value of 23.86% is 251.9% above this benchmark. Historically, Shandong Bailong Chuangyuan Bio-Tech Co's own ROE % has ranged from 11.03 to 21.49 over the past decade. While the company's 10-year median is 14.88 vs. the industry median of 6.78, Shandong Bailong Chuangyuan Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.78, based on 1,925 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Bailong Chuangyuan Bio-Tech Co's current ROE % of 23.86% is 251.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Bailong Chuangyuan Bio-Tech Co's current ROE % is 23.86%, which is 60% above median its own 10-year median of 14.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Fairly Valued. The stock's GF Value™ is ¥22.57, compared to a current price of ¥21.50 — trading 4.7% below its estimated fair value. The current ROE % is 23.86%, which is 60% above median its 10-year median of 14.88 and 251.9% above the Consumer Packaged Goods industry median of 6.78. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current ROE % is 23.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued. The current stock price of ¥21.50 is trading 4.7% below its estimated GF Value™ of ¥22.57. GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Fairly Valued.

Key valuation signals for SHSE:605016:

  • ROE %: 23.86% (60% above median its 10-year median of 14.88)
  • GF Value™: ¥22.57 vs. price of ¥21.50 (4.7% below fair value)
  • GF Score™: 96/100 with 3 warning signs
  • Industry Position: 251.9% above the Consumer Packaged Goods median (#239 of 1925)

No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Bailong Chuangyuan Bio-Tech Co Business Description

Address Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
96GF Score

Get the complete analysis for SHSE:605016

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.50
Price
¥22.57
GF Value